Holger Buhl_Germany
0 (0 Likes / 0 Dislikes)
Hello Gileads! Gilead Sciences is celebrating its 30th anniversary.
I, Holger Buhl, have been here for the past 15 years.
The high point was in 2002: The approval of Viread.
Viread would later be formulated with two other components into one pill, creating the a so-called “single tablet regimen.”
This is something that was brought forward by Gilead Sciences.
Today, we have improved the backbone of HIV therapy with the TAF drugs
And Gilead – in the future Gilead will discover a cure! I am looking forward to it!